KJ-103(Kisoji Biotechnology)

N/A

Report date: 2023/07/14 18:37:39

Base Information

Drug NameKJ-103(Kisoji Biotechnology)
Drug Alias NameKJ-103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Trop-2
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKisoji Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesKisoji Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A